PGAM5 and Parkinson disease: This study was aimed at evaluating the effects of phosphoglyceromutase 5 (PGAM5) overexpression in the cellular model of Parkinson`s disease, 6-hydroxydopamine (6-OHDA)-treated differentiated human embryonic mesencephalic cells of the Lund Human Mesencephalic (LUHMES) cell line.